Provided by Tiger Trade Technology Pte. Ltd.

Nexalin Technology, Inc.

0.4633
-0.0012-0.26%
Post-market: 0.47230.0090+1.94%19:13 EDT
Volume:115.14K
Turnover:52.94K
Market Cap:9.54M
PE:-0.92
High:0.4801
Open:0.4570
Low:0.4480
Close:0.4645
52wk High:2.00
52wk Low:0.3302
Shares:20.58M
Float Shares:17.86M
Volume Ratio:0.16
T/O Rate:0.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5016
EPS(LYR):-0.5016
ROE:-221.50%
ROA:-118.41%
PB:2.54
PE(LYR):-0.92

Loading ...

BUZZ-U.S. STOCKS ON THE MOVE-Nike, PNC Financia, OSI Systems

Reuters
·
Apr 16

Nexalin targets Q2 FDA Q-Submission update for Alzheimer’s De Novo pathway

Reuters
·
Apr 15

Nexalin Advances FDA Alzheimer’s Strategy Following Landmark Leadership Meetings in the U.S. and China

THOMSON REUTERS
·
Apr 15

Nexalin Technology Inc: Plans to Submit an Amended FDA Q-Submission Application Based on Strategy Meetings in Q2 2026

THOMSON REUTERS
·
Apr 15

Nexalin to present at RedChip-hosted live investor webinar with Q&A session

Reuters
·
Apr 14

EXCLUSIVE: Nexalin Study Flags Reduced Self-Injury In Adolescents Using Brain Stimulation Device

Benzinga_recent_news
·
Apr 09

Morgan Stanley Sticks to Its Buy Rating for Nuix Ltd. (NXL)

TIPRANKS
·
Apr 09

Nexalin Technology price target lowered to $2 from $4 at Maxim

TIPRANKS
·
Apr 07

Nexalin Technology FY2025 net loss widens 8% to $8.2 million; revenue jumps 79% to $301,647

Reuters
·
Mar 25

Nexalin Technology Inc expected to post a loss of 12 cents a share - Earnings Preview

Reuters
·
Mar 10

Nuix Ltd. (NXL) Receives a Buy from Morgan Stanley

TIPRANKS
·
Feb 25

Nexalin announces continued advancement toward trial evaluating HALO Clarity

TIPRANKS
·
Feb 24

BRIEF-Nexalin Announces Pivotal Halo™ Clarity Trial

Reuters
·
Feb 24

Nexalin Announces Pivotal Halo™ Clarity Trial to Support Planned De Novo FDA Submission Targeting Multi-Billion-Dollar Insomnia Market

THOMSON REUTERS
·
Feb 24

EXCLUSIVE: Penny Stock Nexalin Advances Pivotal Trial Aiming To Tackle Severe Insomnia

Benzinga_recent_news
·
Feb 24

Nuix Ltd. (NXL) was upgraded to a Buy Rating at RBC Capital

TIPRANKS
·
Feb 23

Nexalin ‘commended’ recent Congressional initiative on neurostim research

TIPRANKS
·
Feb 23

Should You Think About Buying Nuix Limited (ASX:NXL) Now?

Simply Wall St.
·
Feb 13

Nexalin Technology Partners with UC San Diego to Launch AI-Driven NeuroCare Virtual Clinic

Reuters
·
Feb 05

Nexalin Technology highlights research validating neurostimulation technology

TIPRANKS
·
Feb 02